Key result
Co-treatment with alpha-linolenic acid significantly attenuated doxorubicin-induced cardiotoxicity in rats by enhancing antioxidant defense and anti-apoptotic pathways.
Authors
Loading...
Should not yet change doxorubicin regimens; leaves open translation of rat cardioprotection to human trials.
RCT
Randomly divided
Yu et al. (2013) conducted an RCT in Doxorubicin-induced cardiotoxicity. alpha-Linolenic acid (ALA) vs. Doxorubicin alone, normal saline, and ALA alone was evaluated on Cardiotoxicity markers including heart weight, BNP, CK-MB, LDH, cTnI, and myocardial necrosis. Co-treatment with alpha-linolenic acid significantly attenuated doxorubicin-induced cardiotoxicity in rats by enhancing antioxidant defense and anti-apoptotic pathways.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: